Antibacterial Effect of Miswak Toothpaste Compared to Fluoride Toothpaste
1 other identifier
interventional
32
1 country
1
Brief Summary
Meswak is scientifically formulated herbal toothpaste with pure extract of the Miswak plant 'Salvadore Persica', the famous 'Toothbrush Tree' used for centuries. The astringent and anti-bacterial properties of Meswak helps reduce tooth decay , fight plaque and prevent gum diseases. Miswak Herb is a rare, potent, priceless, wonder herb that delivers incredible Dental Care benefits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 15, 2021
CompletedFirst Posted
Study publicly available on registry
November 5, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedNovember 5, 2021
October 1, 2021
4 months
October 15, 2021
October 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
streptococcus mutans count
Counting streptococcus mutans, Measurement: Mitis-Salivarius agar plate, Unit: CFUs/mL
3 months
Study Arms (2)
Miswak toothpaste
EXPERIMENTALDabur meswak herpal toothpaste
Fluoride toothpaste
ACTIVE COMPARATORSignal fluoride toothpaste, containing 1450 ppm of fluoride
Interventions
Dabur Meswak is scientifically formulated herbal toothpaste with pure extract of the Miswak plant 'Salvadore Persica'
1450 ppm fluoride toothpaste
Eligibility Criteria
You may qualify if:
- High caries risk patients.
- At least one carious tooth according to CAT caries risk assessment model.
- Patient compliance
You may not qualify if:
- Participant in another trial.
- Using another antimicrobial agents since one month of sampling.
- Systemic diseases or concomitant medication affecting salivary flow.
- Parafunctional habits.
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Dentistry, Cairo University
Cairo, El Manial, 11553, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Omar O Shaalan, PhD
Lecturer, Conservative Dentistry Department, Faculty of Dentistry, Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer, Conservative Dentistry Department, Faculty of Dentistry
Study Record Dates
First Submitted
October 15, 2021
First Posted
November 5, 2021
Study Start
December 1, 2021
Primary Completion
March 30, 2022
Study Completion
April 30, 2022
Last Updated
November 5, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will not share